205 related articles for article (PubMed ID: 22319031)
1. Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia.
Kanakis G; Kaltsas G; Granberg D; Grimelius L; Papaioannou D; Tsolakis AV; Öberg K
J Clin Endocrinol Metab; 2012 Apr; 97(4):E627-31. PubMed ID: 22319031
[TBL] [Abstract][Full Text] [Related]
2. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
Milanesi A; Yu R; Wolin EM
Pancreatology; 2013; 13(3):324-6. PubMed ID: 23719609
[TBL] [Abstract][Full Text] [Related]
3. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor.
Van den Eynden GG; Neyret A; Fumey G; Rizk-Rabin M; Vermeulen PB; Bouizar Z; Body JJ; Dirix LY
Bone; 2007 Apr; 40(4):1166-71. PubMed ID: 17188588
[TBL] [Abstract][Full Text] [Related]
4. [Unusual cause of hypercalcemia in pregnancy].
Mehl L; Schrader J; Winterberg T; Daniels T; Gross A; Weidner U; Clauditz TS; Lock G
Z Gastroenterol; 2021 Feb; 59(2):143-148. PubMed ID: 33556973
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic neuroendocrine tumor with extensive vascularisation and parathyroid hormone-related protein (PTHrP)--associated hypercalcemia of malignancy.
Clemens P; Gregor M; Lamberts R
Exp Clin Endocrinol Diabetes; 2001; 109(7):378-85. PubMed ID: 11573150
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.
Srirajaskanthan R; McStay M; Toumpanakis C; Meyer T; Caplin ME
Neuroendocrinology; 2009; 89(1):48-55. PubMed ID: 18679021
[TBL] [Abstract][Full Text] [Related]
7. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
Milanesi A; Yu R; Geller SA; Burton D; Deftos LJ; Wolin EM
Pancreas; 2011 May; 40(4):634-7. PubMed ID: 21483254
[TBL] [Abstract][Full Text] [Related]
8. Severe hypercalcaemia from secretion of parathyroid hormone-related peptide.
Barakat MT; Ashrafian H; Todd JF; Meeran K; Williams GR
Lancet Oncol; 2004 Oct; 5(10):633-5. PubMed ID: 15465467
[No Abstract] [Full Text] [Related]
9. Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors.
Takeuchi Y; Fukumoto S; Nakayama K; Tamura Y; Yanagisawa A; Fujita T
J Bone Miner Res; 2002 May; 17(5):753-7. PubMed ID: 12009004
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Guarnotta V; Ragni A; Zanata I; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():665698. PubMed ID: 34093441
[TBL] [Abstract][Full Text] [Related]
11. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.
Nakajima K; Tamai M; Okaniwa S; Nakamura Y; Kobayashi M; Niwa T; Horigome N; Ito N; Suzuki S; Nishio S; Komatsu M
Endocr J; 2013; 60(5):557-62. PubMed ID: 23303131
[TBL] [Abstract][Full Text] [Related]
12. First report of ectopic ACTH syndrome and PTHrP-induced hypercalcemia due to a hepatoblastoma in a child.
Grunewald TG; von Luettichau I; Welsch U; Dörr HG; Höpner F; Kovacs K; Burdach S; Rabl W
Eur J Endocrinol; 2010 Apr; 162(4):813-8. PubMed ID: 20133447
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia of malignancy--new insights into an old syndrome.
Esbrit P
Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
[TBL] [Abstract][Full Text] [Related]
14. A patient with a history of breast cancer and multiple bone lesions: a case report.
Schnyder MA; Stolzmann P; Huber GF; Schmid C
J Med Case Rep; 2017 May; 11(1):127. PubMed ID: 28476174
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.
Grill V; Ho P; Body JJ; Johanson N; Lee SC; Kukreja SC; Moseley JM; Martin TJ
J Clin Endocrinol Metab; 1991 Dec; 73(6):1309-15. PubMed ID: 1955513
[TBL] [Abstract][Full Text] [Related]
16. Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report.
Behdadnia A; Jeddi M
J Med Case Rep; 2023 Sep; 17(1):400. PubMed ID: 37670372
[TBL] [Abstract][Full Text] [Related]
17. [Hyperparathyroidism due to parathyroid carcinoma located in the mediastinum].
Boddi W; Nozzoli C; Francois C; Amorosi A; Grifoni S; Morettini A; Olivotto J; Berni G
Ann Ital Med Int; 1994; 9(1):32-4. PubMed ID: 8003390
[TBL] [Abstract][Full Text] [Related]
18. Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET).
Symington M; Davies L; Kaltsas G; Weickert MO
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28331027
[TBL] [Abstract][Full Text] [Related]
19. [PTH-related protein (PTHrP) in serum of patients with tumor hypercalcemia].
Scharla SH; Pecherstorfer M; Lempert UG; Minne HW; Sarrach M; Baumgartner G; Ziegler R
Med Klin (Munich); 1991 Apr; 86(4):186-9. PubMed ID: 2056982
[TBL] [Abstract][Full Text] [Related]
20. Malignant islet cell tumor associated with hypercalcemia.
Mao C; Carter P; Schaefer P; Zhu L; Dominguez JM; Hanson DJ; Appert HE; Kim K; Howard JM
Surgery; 1995 Jan; 117(1):37-40. PubMed ID: 7809834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
